本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cytek BioSciences

4.61
+0.08001.77%
盤後4.610.00000.00%18:19 EDT
成交量:89.77萬
成交額:411.97萬
市值:5.99億
市盈率:-7.32
高:4.64
開:4.61
低:4.49
收:4.53
52周最高:6.18
52周最低:3.28
股本:1.30億
流通股本:1.03億
量比:0.93
換手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):-0.6300
每股收益(LYR):-0.5209
淨資產收益率:-23.04%
總資產收益率:-6.31%
市淨率:1.86
市盈率(LYR):-8.85

資料載入中...

2024/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report